BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10479651)

  • 1. 9-cis retinoic acid induces monocyte chemoattractant protein-1 secretion in human monocytic THP-1 cells.
    Zhu L; Bisgaier CL; Aviram M; Newton RS
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2105-11. PubMed ID: 10479651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
    Kintscher U; Goetze S; Wakino S; Kim S; Nagpal S; Chandraratna RA; Graf K; Fleck E; Hsueh WA; Law RE
    Eur J Pharmacol; 2000 Aug; 401(3):259-70. PubMed ID: 10936484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid.
    Han S; Sidell N
    Immunology; 2002 May; 106(1):53-9. PubMed ID: 11972632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration.
    Tanaka T; Fukunaga Y; Itoh H; Doi K; Yamashita J; Chun TH; Inoue M; Masatsugu K; Saito T; Sawada N; Sakaguchi S; Arai H; Nakao K
    Eur J Pharmacol; 2005 Jan; 508(1-3):255-65. PubMed ID: 15680279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
    Park EY; Cho IJ; Kim SG
    Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis.
    Panzer U; Schneider A; Guan Y; Reinking R; Zahner G; Harendza S; Wolf G; Thaiss F; Stahl RA
    Kidney Int; 2002 Aug; 62(2):455-64. PubMed ID: 12110006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of PPARgamma1 expression in human THP-1 monocytic leukemia cells by 9-cis-retinoic acid is associated with cellular growth suppression.
    Zhu L; Gong B; Bisgaier CL; Aviram M; Newton RS
    Biochem Biophys Res Commun; 1998 Oct; 251(3):842-8. PubMed ID: 9790997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the interleukin-1 receptor antagonist in THP-1 cells by ligands of the peroxisome proliferator-activated receptor gamma.
    Meier CA; Chicheportiche R; Juge-Aubry CE; Dreyer MG; Dayer JM
    Cytokine; 2002 Jun; 18(6):320-8. PubMed ID: 12160520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
    Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of retinoids and thiazolidinediones on proliferation, insulin release, insulin mRNA, GLUT 2 transporter protein and mRNA of INS-1 cells.
    Blumentrath J; Neye H; Verspohl EJ
    Cell Biochem Funct; 2001 Sep; 19(3):159-69. PubMed ID: 11494305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor gamma reduces the growth rate of pancreatic cancer cells through the reduction of cyclin D1.
    Toyota M; Miyazaki Y; Kitamura S; Nagasawa Y; Kiyohara T; Shinomura Y; Matsuzawa Y
    Life Sci; 2002 Feb; 70(13):1565-75. PubMed ID: 11895107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activation of peroxisome proliferator-activated receptor gamma (PPARgamma) on human monocyte function: PPARgamma ligands do not inhibit tumor necrosis factor-alpha release in human monocytic cell line THP-1.
    Naitoh T; Kitahara M; Tsuruzoe N
    Cell Biol Toxicol; 2000; 16(2):131-5. PubMed ID: 10917568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma.
    Haydon RC; Zhou L; Feng T; Breyer B; Cheng H; Jiang W; Ishikawa A; Peabody T; Montag A; Simon MA; He TC
    Clin Cancer Res; 2002 May; 8(5):1288-94. PubMed ID: 12006550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL.
    Tontonoz P; Nagy L; Alvarez JG; Thomazy VA; Evans RM
    Cell; 1998 Apr; 93(2):241-52. PubMed ID: 9568716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
    Zeng X; Dai J; Remick DG; Wang X
    Circ Res; 2003 Aug; 93(4):311-20. PubMed ID: 12881478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of uncoupling protein 3 by thyroid hormone, peroxisome proliferator-activated receptor ligands and 9-cis retinoic acid in L6 myotubes.
    Nagase I; Yoshida S; Canas X; Irie Y; Kimura K; Yoshida T; Saito M
    FEBS Lett; 1999 Nov; 461(3):319-22. PubMed ID: 10567719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiinflammatory and antiarteriosclerotic effects of pioglitazone.
    Ishibashi M; Egashira K; Hiasa K; Inoue S; Ni W; Zhao Q; Usui M; Kitamoto S; Ichiki T; Takeshita A
    Hypertension; 2002 Nov; 40(5):687-93. PubMed ID: 12411463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of constitutive but not Il-1beta-inducible expression of monocyte chemoattractant protein-1 in mesangial cells by retinoic acids: intervention in the activator protein-1 pathway.
    Lucio-Cazana J; Nakayama K; Xu Q; Konta T; Moreno-Manzano V; Furusu A; Kitamura M
    J Am Soc Nephrol; 2001 Apr; 12(4):688-694. PubMed ID: 11274229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.